Singapore markets open in 7 hours 56 minutes

LLY Jan 2026 510.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
18.600.00 (0.00%)
As of 01:01PM EDT. Market open.
Full screen
Previous close18.60
Expiry date2026-01-16
Day's range18.60 - 20.27
Contract rangeN/A
Open interest565
  • Benzinga

    Pfizer And Roche Advance On Their Weight Loss Drug Journeys

    After previously discounting a twice-daily version of its weight loss drug due to patients having difficulties tolerating it, Pfizer Inc (NYSE: PFE) moved forward with the once-daily version. On Thursday, Pfizer revealed it will begin studies to evaluate the optimal dose of its weight lose pill during the second half of the year. With the new formulation, Pfizer continues its attempt to catch up to Eli Lilly and Company (NYSE: LLY) and Novo Nordisk (NYSE: NVO) who are currently dominating the we

  • Benzinga

    Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?

    Eli Lilly And Co (NYSE:LLY), Novo Nordisk A/S (NYSE:NVO), Viking Therapeutics Inc (NASDAQ:VKTX), and Structure Therapeutics Inc (NASDAQ:GPCR) stocks are trading lower on Wednesday. What happened? Earlier on Wednesday, Roche Holdings AG (OTC:RHHBY) announced topline results from two arms of an ongoing multi-part Phase 1 clinical trial for CT-996 for type 2 diabetes and obesity. The data showed that treatment with CT-996 in participants with obesity and without type 2 diabetes resulted in a clinic


    Eli Lilly, Novo Nordisk Stocks Are Dropping. A Rival Had Upbeat Weight-Loss News.

    Roche said that a Phase 1 clinical trial for CT-996, a once-daily oral GLP-1 receptor, showed positive top-line results.